0001179110-12-006484.txt : 20120404
0001179110-12-006484.hdr.sgml : 20120404
20120404181813
ACCESSION NUMBER: 0001179110-12-006484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120402
FILED AS OF DATE: 20120404
DATE AS OF CHANGE: 20120404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTIN JOHN C
CENTRAL INDEX KEY: 0001190578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 12743253
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: X1
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
edgar.xml
FORM 4 -
X0305
4
2012-04-02
0
0000882095
GILEAD SCIENCES INC
GILD
0001190578
MARTIN JOHN C
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
0
0
Chairman and CEO
Common Stock
2012-04-02
4
M
0
145450
8.9425
A
2134655
D
Common Stock
2012-04-02
4
S
0
145450
48.3798
D
1989205
D
Non-Qualified Stock option (right to buy)
8.9425
2012-04-02
4
M
0
145450
0
D
2013-01-28
Common Stock
145450
1152470
D
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
The exercise and sale transactions reported in this Form 4 made pursuant to a Rule 10b5-1 trading plan established by Dr. Martin on December 12, 2011.
Sale prices reported for the transactions reported here range from $47.86 to $48.78. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ John C. Martin
2012-04-04